![Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil | Nature Communications Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-33169-0/MediaObjects/41467_2022_33169_Fig1_HTML.png)
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil | Nature Communications
![Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study - The Lancet Infectious Diseases Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/d5e4aaa1-b941-40ba-9d8a-7434e25acd80/gr1_lrg.jpg)
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study - The Lancet Infectious Diseases
![Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021 | MMWR Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7038e2_ACIPPfizerAuthorization_IMAGE_21Sept21_1200x627.jpg?_=50021)
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021 | MMWR
Myths and Facts About the Vax — Debunking Common COVID-19 Vaccine Myths > TRICARE Newsroom > Articles
![Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine](https://www.thelancet.com/cms/asset/2e79c946-a76f-459d-8e49-c3f1fef08276/gr1.jpg)
Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine
![County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis - The Lancet Regional Health – Americas County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis - The Lancet Regional Health – Americas](https://www.thelancet.com/cms/attachment/160be32f-da64-40a6-b6ae-0338973df2c4/gr1_lrg.jpg)
County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis - The Lancet Regional Health – Americas
![Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August ... Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August ...](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7037e2_VEEDClinics_IMAGE_10Sept21_1200x627.jpg?_=69825)
Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August ...
![Vaccines | Free Full-Text | Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study Vaccines | Free Full-Text | Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study](https://www.mdpi.com/vaccines/vaccines-10-00479/article_deploy/html/images/vaccines-10-00479-g001.png)
Vaccines | Free Full-Text | Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study
![Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7137a3_PneumococcalConjugateVax_IMAGE_16Sep22_900x675.jpg?_=62589)